Efficacy of Irinotecan as Third-Line Chemotherapy for Unresectable or Recurrent Gastric Cancer

In Vivo - Greece
doi 10.21873/invivo.11856
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Anticancer Research USA Inc.

Related search

Combination Chemotherapy With Irinotecan and Cisplatin in Pretreated Patients With Unresectable or Recurrent Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2006English

Irinotecan Monotherapy as Third-Line or Later Treatment in Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2017English

Weekly Paclitaxel as Second-Line Chemotherapy for Advanced or Recurrent Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2006English

Safety and Continuity of Second- And Third-Line Therapy With Paclitaxel or Irinotecan for Advanced and Recurrent Gastric Cancer

Molecular and Clinical Oncology
Cancer ResearchOncology
2014English

Association Between UGT1A1 Gene Polymorphism and Safety and Efficacy of Irinotecan Monotherapy as the Third-Line Treatment for Advanced Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2019English

Prognostic Factors of Second and Third Line Chemotherapy Using 5-Fu With Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer

Cancer Research and Treatment
Cancer ResearchOncology
2011English

Outcomes of Third-Line Docetaxel-Based Chemotherapy in Advanced Gastric Cancer Who Failed Previous Oxaliplatin-Based and Irinotecan-Based Chemotherapies

Cancer Research and Treatment
Cancer ResearchOncology
2012English

5 Fluorouracil, Leucovorin, and Irinotecan (FOLFIRI) as a Third-Line Chemotherapy Treatment in Metastatic Gastric Cancer, After Failure of Fluoropyrimidine, Platinum, Anthracycline, and Taxane

Bosnian Journal of Basic Medical Sciences
Medicine
2017English

First-Line Single-Agent Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer With Poor Performance Status

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy